Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids—and which might only suffer their side effects—with help from a dozen clinical ...
Feb 20, 2019
0
2
New research suggests a maternal vaccination against RSV should be augmented with active immunisation in a child's first two years to reduce the onset of asthma.
Dec 5, 2018
0
7
In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways. These patients with the type 2 (T2) endotype may benefit ...
Oct 22, 2018
0
7
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...
May 22, 2018
0
29
Asthma outcomes still vary widely across England and appear to be influenced by region and affluence despite falling rates of asthma deaths, emergency hospital admissions and prevalence, suggests a study published in the ...
May 14, 2018
0
2
Researchers at Western University and McMaster University are developing an innovative lung imaging method that provides a unique window on asthma that is aimed at guiding and personalizing treatment for Canadians with severe, ...
Apr 4, 2018
0
2
A team of researchers from the NIHR Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung ...
Mar 14, 2018
0
219
Serious asthma attacks in adults can be reduced by a temporary but significant increase in the dose of inhaled steroids during severe episodes of asthma, according to a new UK-wide study led by experts at the University of ...
Mar 8, 2018
0
6
A team at The University of Manchester have found that in a minority of patients they studied, a standard treatment for asthma—oral steroids—was associated with increased levels of the treatable mould Aspergillus in the ...
Jan 15, 2018
0
36
(HealthDay)—Nucala (mepolizumab) has been approved by the U.S. Food and Drug Administration as the first remedy to treat adults with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that leads to ...
Dec 12, 2017
0
14
